Clearstead Advisors, LLC Atri Cure, Inc. Transaction History
Clearstead Advisors, LLC
- $6.31 Billion
- Q3 2024
A detailed history of Clearstead Advisors, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 187 shares of ATRC stock, worth $5,656. This represents 0.0% of its overall portfolio holdings.
Number of Shares
187
Previous 549
65.94%
Holding current value
$5,656
Previous $12,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$141 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$140 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$120 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$85.6 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$84.4 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.4B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...